1. Home
  2. VIR vs ADAM Comparison

VIR vs ADAM Comparison

Compare VIR & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ADAM
  • Stock Information
  • Founded
  • VIR 2016
  • ADAM 2003
  • Country
  • VIR United States
  • ADAM United States
  • Employees
  • VIR N/A
  • ADAM N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ADAM Computer Software: Prepackaged Software
  • Sector
  • VIR Health Care
  • ADAM Technology
  • Exchange
  • VIR Nasdaq
  • ADAM Nasdaq
  • Market Cap
  • VIR 706.4M
  • ADAM 660.2M
  • IPO Year
  • VIR 2019
  • ADAM N/A
  • Fundamental
  • Price
  • VIR $5.63
  • ADAM $6.82
  • Analyst Decision
  • VIR Strong Buy
  • ADAM
  • Analyst Count
  • VIR 11
  • ADAM 0
  • Target Price
  • VIR $25.73
  • ADAM N/A
  • AVG Volume (30 Days)
  • VIR 1.1M
  • ADAM 776.6K
  • Earning Date
  • VIR 10-30-2025
  • ADAM 10-29-2025
  • Dividend Yield
  • VIR N/A
  • ADAM 11.77%
  • EPS Growth
  • VIR N/A
  • ADAM N/A
  • EPS
  • VIR N/A
  • ADAM 0.19
  • Revenue
  • VIR $19,000,000.00
  • ADAM $205,403,000.00
  • Revenue This Year
  • VIR N/A
  • ADAM $14.09
  • Revenue Next Year
  • VIR $15.25
  • ADAM $27.41
  • P/E Ratio
  • VIR N/A
  • ADAM $35.41
  • Revenue Growth
  • VIR N/A
  • ADAM 23.27
  • 52 Week Low
  • VIR $4.16
  • ADAM $5.02
  • 52 Week High
  • VIR $14.45
  • ADAM $7.52
  • Technical
  • Relative Strength Index (RSI)
  • VIR 59.22
  • ADAM N/A
  • Support Level
  • VIR $5.36
  • ADAM N/A
  • Resistance Level
  • VIR $6.00
  • ADAM N/A
  • Average True Range (ATR)
  • VIR 0.28
  • ADAM 0.00
  • MACD
  • VIR 0.03
  • ADAM 0.00
  • Stochastic Oscillator
  • VIR 65.62
  • ADAM 0.00

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ADAM Adamas Trust Inc. Common Stock

Adamas Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.

Share on Social Networks: